| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |